Chronic myeloid leukaemia in four Norwegian health regions, 1990-96;Kronisk myelogen leukemi i helseregion 1, 3, 4 og 5 i perioden 1990-96

Tidsskrift for den Norske Laegeforening

Volumn 119, Issue 12, 1999, Pages 1733-1736

  Lamvik, Jon ^a   Brinch, Lorentz ^b   Dahl, Inger Marie S ^c   Sjo, Malvin ^c   Nesthus, Ingerid ^d   Tangen, Jon Magnus ^e   Berentsen, Sigbjorn ^f   Ly, Bernt ^g   Shammas, Fuad Victor ^h  

^a Medisinsk Avdeling   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c Medisinsk Avdeling   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e Hematologisk Avdeling   (Norway)

^f Medisinsk Avdeling   (Norway)

^g AKER UNIVERSITY HOSPITAL   (Norway)

^h Medisinsk Avdeling   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CAUSE OF DEATH; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NORWAY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; CAUSE OF DEATH; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; NORWAY; PROGNOSIS;

EID: 0033541806     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Groves ID, Linet MS, Devosa SS. Patterns of occurrence of the leukemias. Eur J Cancer 1995; 31A: 941-9.
2. Brincker H. Population-based age- and sex-specific incidence rates in the 4 main types of leukaemia. Scand J Haematol 1982; 29: 241-9.
3. Gomez GA, Sobol JE, Walsh B. Prognostic features at diagnosis of chronic myelocytic leukemia. Cancer 1981; 47: 2470-7.
4. Cervantes R, Rozman C. A multivariate analysis of prognostic factors in chronic myeloid leukemia. Blood 1982; 60: 1298-304.
5. Hehlmann R, Heimpel H, Hasford J, Kolb HJ, Pralle H, Horsfeld DK et al. Randomized comparison of interferon-α with busulfan and hydroxyurea in chronic myelogenous leukemia. Blood 1994; 84: 4064-77.
6. Ohnishi K, Ohno R, Tomonaga M, Kamada N, Onozawa K, Kuramoto A et al. A randomized trial comparing interferon-α with busulfan for newly diagnosed chronic myelogenous leukemia in chronic phase. Blood 1995; 86: 906-16.
7. Spiers ASD. The chronic myeloid leukemias. I: Whittaker JA, red. Leukemia. 2. utg. Oxford: Blackwell Scientific Publications, 1992: 434-67.
8. Medical Research Council. Chronic granulocytic leukemia: comparison of radiotherapy and busulfan therapy. BMJ 1968; 1: 201-8.
9. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. Interferon-2α as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. N Engl J Med 1994; 330: 820-5.
10. Kantarijan HM, O'Brien S, Anderlini P, Talpaz M. Treatment of chronic myelogenous leukemia: current status and investigational options. Blood 1996; 87: 3069-81.